The genetic overexpression of SIRT1 has also been shown to protect mice from obesity-promoted hepatocarcinogenesis [50], suggesting that SIRT1 is a potential molecular target for dietary and therapeutic agents against HCC development. This evidence concerns the gene SIRT1 and hepatocellular carcinoma.